Resumen
La anafilaxia es una situación que pone en peligro la vida y puede ocurrir a cualquier edad. Desafortunadamente, a pesar de que existen lineamientos actualizados para su tratamiento, muchos pacientes son diagnosticados y tratados erróneamente y en ocasiones se reportan muertes. En este artículo se resumen las dificultades y errores más comunes que hemos observado repetidamente en pacientes que consultan a nuestros servicios por haber padecido episodios de anafilaxia con el objeto de proporcionar orientación acerca de la implementación de los planes para el tratamiento de estas reacciones. Las recomendaciones incluidas en este documento se derivan de los lineamientos mencionados.
Referencias
Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, et al; World Allergy Organization. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011;4:13-37.
Simons FE, Ardusso LR, Bilò MB, Dimov V, et al; World Allergy Organization. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012;12:389-399.
Simons FE, Ardusso LR, Dimov V, Ebisawa M, et al; World Allergy Organization. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013;162:193-204.
Muraro A, Roberts G, Worm M, Bilò MB, et al; EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014. doi: 10.1111/all.12437.
Simons FE, Ardusso LR, Bilò MB, Cardona V, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014;7:9.
Neffen HE, Sánchez-Borges M, González-Broin M, Cardona V. Knowledge and management of anaphylaxis in primary care settings in Spain and Latin America. 30th Congress of the European Academy of Allergy and Clinical Immunology. Istanbul, 11-15 June 2011. (Abstract).
Sole D, Ivancevich JC, Cardona V. Knowledge of anaphylaxis among Ibero-American physicians: Results of the IberoAmerican Online Survey for Physicians on the Management and Treatment of Anaphylaxis (IOSPTA). Latin American Society of Allergy, Asthma & Immunology (LASAAI). J Investig Allergol Clin Immunol 2013;23:435-447.
Rueff F, Przybilla B, Biló MB, Müller U, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009;124:1047-1054.
Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011;128:147-152.
González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010;125:1098-1104.
Calvani M, Cardinale F, Martelli A, Muraro A, et al; Italian Society of Pediatric Allergy and Immunology Anaphylaxis’ Study Group. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011;22:813-819.
Hompes S, Köhli A, Nemat K, Scherer K, et al. Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol 2011;22:568-574.
Cardona V, Luengo O, Garriga T, Labrador-Horrillo M, et al. Co-factor-enhanced food allergy. Allergy 2012;67:1316-1318.
Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 2001;108:861-866.
Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010;126:477-480.
Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-397.
Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007;7:337-341.
Sole D, Ivancevich JC, Sánchez-Borges M, Rosario N, et al. Anaphylaxis in Latin America: A report of the Online Latin American Survey on Anaphylaxis (OLASA). Clinics 2011;66:943-947.
Sole D, Ivancevich JC, Sánchez-Borges M, Coelho MA, et al, Latin American Anaphylaxis Working Group. Anaphylaxis in Latin American children and adolescents: the Online Latin American Survey on Anaphylaxis (OLASA). Allergologia et Immunopathologia 2012;40:331-335.
Kemp SF, Lockey RF, Simons FE; World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis-a statement of the World Allergy Organization. World Allergy Organ J 2008;1:S18-S26.
Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004;113:837-844.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2014 Revista Alergia México